PHARMIGEX THERAPEUTICS SL
Company details
- Active NIF/CIF: Not available
-
-
-
-
Address: Calle Alcalde Velasco Navarro, 10, 14004 Córdoba, España See in map
-
-
Intracommunity VAT: Not available
Featured products:
More information on PHARMIGEX THERAPEUTICS SL
-
08/09/2020 | BORME act no.: 302218 | Register: CÓRDOBACierre provisional hoja registral por baja en el índice de Entidades Jurídicas
-
05/09/2016 | BORME act no.: 363896 | Register: CÓRDOBAConstitución
-
05/09/2016 | BORME act no.: 363896 | Register: CÓRDOBADeclaración de unipersonalidad
-
05/09/2016 | BORME act no.: 363896 | Register: CÓRDOBANombramientos
Other information
The CIF assigned to PHARMIGEX THERAPEUTICS SL is -, while its current business status is active. The company operates in the economic sector identified by the CNAE 2059 - Fabricación de otros productos químicos n.c.o.p.. In addition, its activity corresponds to the SIC classification 28 - Productos químicos.
The template of PHARMIGEX THERAPEUTICS SL includes Between 1 and 9 employees, and the company reports an annual turnover of less than 2 million euros. PHARMIGEX THERAPEUTICS SL is registered in the Mercantile Registry of Córdoba and accumulates a total of 2 registration charges. The most recent announcement in Borme was published on 08/09/2020, while its last deposit of ordinary annual accounts is related to the - exercise.
If you want to obtain contact information for PHARMIGEX THERAPEUTICS SL, such as the telephone number, postal address, or website, you can consult our Company Data module.
To access more details about PHARMIGEX THERAPEUTICS SL, consider reviewing one of our available financial reports, the company's Annual Accounts, or verifying its outstanding payments registered in the RAI delinquency file.
The financial, commercial, and legal information provided about PHARMIGEX THERAPEUTICS SL comes from official data sources and is automatically updated every day.
Do you want to know more about PHARMIGEX THERAPEUTICS SL??
Find out more about this company by consulting these reports: